The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses-Reference-Cited by-同舟云学术

The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses

Published:2024-06-04 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Fisman David¹,Giglio Norberto²,Levin Myron J.³,Nguyen Van Hung⁴,Pelton Stephen I.⁵,Postma Maarten⁶⁷⁸⁹,Ruiz-Aragón Jesús¹⁰,Urueña Analia¹¹,Mould-Quevedo Joaquin F.¹²

Affiliation:

1. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

2. Servicio de Consultorios Externos de Pediatría. Hospital de Niños Ricardo Gutiérrez, Ciudad Autónoma de Buenos Aires, Argentina

3. Departments of Pedatrics and Medicine, University of Colorado School of Medicine, Denver, Colorado, United States

4. VNH Consulting, Montreal, Québec, Canada

5. Department of Health Sciences, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA

6. Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

7. Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia

8. Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands

9. Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

10. Hospital de la Línea de la Concepción, Cádiz, Spain

11. Centro de Estudios para la Prevención y Control de Enfermedades Transmisibles, Universidad Isalud, Buenos Aires, Argentina

12. CSL Seqirus Inc., Summit, New Jersey, USA

Funder

the medical communications agency Scion

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2351675

Reference63 articles.

1. The economic burden of influenza among adults aged 18 to 64: A systematic literature review

2. Seasonal influenza in children: Costs for the health system and society in Europe

3. World Health Organization. Influenza. https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/influenza#:~:text=Influenza%20occurs%20all%20over%20the disruption%20across%20all%20age%20groups.

4. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project

5. The burden of seasonal and pandemic influenza in infants and children